지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.3
- 수록면
- 1 - 13 (13page)
- DOI
- 10.3346/jkms.2024.39.e76
이용수
초록· 키워드
오류제보하기
Background: During coronavirus disease 2019 (COVID-19) pandemic, several COVID-19 vaccines were licensed with fast-track procedures. Although these vaccines have demonstrated high immunogenicity, there has been concerns on the serious adverse events (AEs) following COVID-19 vaccination among adolescents. We aimed to analyze comparative safety of COVID-19 vaccination in adolescents.
Methods: In this pharmacovigilance study, we performed a disproportionality analysis using VigiBase, the World Health Organization’s global individual case safety report (ICSR) database. To compare serious AEs reported following COVID-19 vaccines vs. all other vaccines in adolescents aged 12–17 years, ICSRs following any vaccines on adolescents aged 12–17 years were included, defining cases as reports with the AEs of interest, with all other AEs as non-cases. The AEs of interest were myocarditis/pericarditis, multisystem inflammatory syndrome/Kawasaki disease (MIS/KD), anaphylaxis, Guillain-Barré syndrome (GBS), and immune thrombocytopenia (ITP). We conducted a disproportionality analysis to estimate reporting odds ratio (ROR) with 95% confidence interval (CI) for each AE of interest, adjusted for sex by using logistic regression.
Results: Of 99,735 AE reports after vaccination in adolescents, 80,018 reports were from COVID-19 vaccinated adolescents (52.9% females; 56.3% America). The AEs of interest were predominantly reported as serious AE (76.1%) with mRNA vaccines (99.4%). Generally, higher reporting odds for the AEs were identified following COVID-19 vaccination in adolescents; myocarditis/pericarditis (2,829 reports for the COVID-19 vaccine vs. 35 for all other vaccines, adjusted ROR [aROR], 19.61; 95% CI, 14.05–27.39), and MIS/KD (104 vs. 6, aROR, 4.33; 95% CI, 1.89–9.88). The reporting odds for anaphylaxis (515 vs. 165, aROR, 0.86; 95% CI, 0.72– 1.02), GBS (94 vs. 40, aROR, 0.64; 95% CI, 0.44–0.92) and ITP (52 vs. 12, aROR, 1.12; 95% CI, 0.59–2.09) were not significantly higher following COVID-19 vaccination.
Conclusion: In this study, there were disproportionate reporting of immune-related AEs following COVID-19 vaccination. While awaiting definitive evidence, there is a need to closely monitor for any signs of immune-related AEs following COVID-19 vaccination among adolescents.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Efficacy and Safety of COVID-19 Vaccines in Adolescents: Systematic Review of Randomized Controlled Studies and Observational Studies
Pediatric Infection and Vaccine
2024 .04
-
COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021
Osong Public Health and Research Persptectives
2021 .12
-
COVID-19 Vaccination in Korea
Infection and Chemotherapy
2023 .03
-
COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021
Osong Public Health and Research Persptectives
2021 .08
-
Expert Consensus on COVID-19 Vaccination in Korean Adolescents: A Modified Delphi Survey
Journal of Korean Medical Science
2022 .03
-
일개 한의과대학 재학생의 COVID-19 백신 접종에 대한 인식 조사
대한예방한의학회지
2021 .12
-
A Nationwide Survey of mRNA COVID-19 Vaccinee’s Experiences on Adverse Events and Its Associated Factors
Journal of Korean Medical Science
2023 .06
-
소아청소년에서 Coronavirus Disease 2019 백신에 대한 이상 반응
Allergy Asthma & Respiratory Diseases
2022 .01
-
건강신념모형을 적용한 국내 대학생 코로나19 백신 접종 의도의 영향요인
보건교육건강증진학회지
2022 .03
-
Short-term safety profile of COVID-19 vaccination in children and adolescents with underlying medical conditions: a prospective cohort study
Childhood Kidney Diseases
2023 .06
-
Association of COVID-19 vaccine attitudes and cognitions of COVID-19-related stigma with vaccine hesitancy among college students
한국간호교육학회지
2022 .08
-
COVID-19 Vaccination and Clinical Outcomes at a Secondary Referral Hospital During the Delta Variant-dominant Period in West Sumatra, Indonesia
예방의학회지
2023 .05
-
The Role of COVID-19 Vaccination for Patients With Atherosclerotic Cardiovascular Disease in the Upcoming Endemic Era
지질·동맥경화학회지
2024 .01
-
Adverse events and preventive measures related to COVID-19 vaccines
Clinical and Experimental Emergency Medicine
2021 .09
-
Post-vaccination COVID-19 deaths: a review of available evidence and recommendations for the global population
Clinical and Experimental Vaccine Research
2021 .09
-
Exploring the underlying factors of COVID-19 vaccination hesitancy in Ahvaz, Iran: a comprehensive cross-sectional study
Clinical and Experimental Vaccine Research
2023 .04
-
Pediatric and Parents' Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children
Journal of Korean Medical Science
2021 .01
-
Early-Onset Myasthenia Gravis Following COVID-19 Vaccination
Journal of Korean Medical Science
2022 .03
-
Perceptions of the COVID-19 vaccine and willingness to receive vaccination among health workers in Nigeria
Osong Public Health and Research Persptectives
2021 .08
-
Should steroids be used for anaphylaxis after the COVID-19 vaccine?
Clinical and Experimental Emergency Medicine
2021 .12
최근 본 자료
댓글(0)
0